Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Molecules (Basel, Switzerland)|January 5, 2021
Improved Synthesis of Phosphoramidite-Protected N6-Methyladenosine via BOP-Mediated SNAr ReactionShifali Shishodia, Christopher J SchofieldNucleic Acids Research|August 28, 2025
Evidence human FTO catalyses hydroxylation of N6-methyladenosine without direct formation of a demethylated product contrasting with ALKBH5/2/3 and bacterial AlkBSimranjeet Kaur, Pratheesh Maheswaran, Samanpreet Kaur, et al.ACS Medicinal Chemistry Letters|October 15, 2025
Polybromo‑1 Bromodomain Inhibitor Selectivity Is Mediated by a Unique Ligand-Binding PocketRaymundo Nuñez, Karina L Bursch, Savannah J Makowski, et al.ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.Journal of Medical Genetics|September 18, 2015
Identification of a pathogenic FTO mutation by next-generation sequencing in a newborn with growth retardation and developmental delayHussein Daoud, Dong Zhang, Fiona McMurray, et al.Journal of Medicinal Chemistry|November 11, 2021
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) InhibitorsShifali Shishodia, Marina Demetriades, Dong Zhang, et al.Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.Nature Chemistry|December 14, 2021
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitorsJürgen Brem, Tharindi Panduwawala, Jon Ulf Hansen, et al.Pageof 1